Skip to main content
. 2024 Apr 24;70(7):689–700. doi: 10.1159/000535968

Table 1.

Demographic characteristics of perturbation-related female fallers (PFs) versus perturbation-related female non-fallers (PNFs)

Characteristic PF (N = 10) PNF (N = 49) p value
Age, years 79.35±4.35 78.71±5.40 t = −0.35 0.728
Reported a fall in last year, % (n) 80.0 (n = 8) 38.7 (n = 19) χ2 = 5.67 0.017
Mini-Mental State Examination 29 (26, 30) 29 (25, 30) z = −1.34 0.178
Number of diseases diagnosed 2 (0, 4) 1 (0, 8) z = 0.37 0.465
Number medications/day 3.5 (1, 7) 4 (1, 10) z = −0.30 0.759
Height, cm 153.40±6.09 156.36±8.04 t = 1.10 0.276
Weight, kg 61.90±8.87 65.95±13.67 t = 0.89 0.373
BMI, kg/m2 26.26±3.01 29.94±4.44 t = 0.46 0.644
Fall Efficacy Scale (FES-I) 29 (16, 58) 19 (16, 46) z = 1.97 0.048
Late Life Function
 Overall function 53.65 (50.32, 100) 65.02 (45.22, 79.35) z = −2.21 0.026
 Upper extremity function 71.19 (57.64, 100) 77.50 (51.27, 100) z = −1.00 0.324
 Basic lower extremity function 61.84 (54.05, 100) 81.17 (53.35, 100) z = −2.43 0.014
 Advanced lower extremity function 47.25 (33.12, 100) 57.00 (34.59, 81.36) z = −1.92 0.054

Values are means ± 1 SD where a variable was normally distributed using an independent t test (age, weight, height, and BMI), and medians (Min, Max) where a variable was not normally distributed using a Mann-Whitney U test (Mini-Mental State Examination score, number of diagnosed diseases, number of medications per day, Fall Efficacy Scale, and Late Life Function scores), and χ2 for number of retro-fallers. Significant differences between PFs and PNFs (p value <0.05).

t indicates group comparison based on t test; z indicates group comparison based on Mann-Whitney U test, and χ2 indicates group comparison based on χ2 testing.